BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29880282)

  • 1. Enhanced bacterial cancer therapy with hydroxychloroquine liposomes.
    Park K
    J Control Release; 2018 Jun; 280():124. PubMed ID: 29880282
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiating bacterial cancer therapy using hydroxychloroquine liposomes.
    Wang Y; Zhou Z; Chen W; Qin M; Zhang Z; Gong T; Sun X
    J Control Release; 2018 Jun; 280():39-50. PubMed ID: 29730153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Molecular Machines in Nanotheranostics.
    Yu G; Yung BC; Zhou Z; Mao Z; Chen X
    ACS Nano; 2018 Jan; 12(1):7-12. PubMed ID: 29283247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-functional liposomes showing radiofrequency-triggered release and magnetic resonance imaging for tumor multi-mechanism therapy.
    Du B; Han S; Li H; Zhao F; Su X; Cao X; Zhang Z
    Nanoscale; 2015 Mar; 7(12):5411-26. PubMed ID: 25731982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy.
    Ma J; Wu H; Li Y; Liu Z; Liu G; Guo Y; Hou Z; Zhao Q; Chen D; Zhu X
    Pharm Res; 2018 Feb; 35(3):57. PubMed ID: 29423532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy.
    Zhang K; Zhang Y; Meng X; Lu H; Chang H; Dong H; Zhang X
    Biomaterials; 2018 Dec; 185():301-309. PubMed ID: 30265899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-particle characterization of theranostic liposomes with stimulus sensing and controlled drug release properties.
    Chen C; Gao K; Lian H; Chen C; Yan X
    Biosens Bioelectron; 2019 Apr; 131():185-192. PubMed ID: 30836270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-functional peptide-modified liposomes for treatment of glioma.
    Park K
    J Control Release; 2018 Nov; 289():171. PubMed ID: 30724172
    [No Abstract]   [Full Text] [Related]  

  • 9. The drug delivery field needs a well-diversified technology portfolio.
    Park K
    J Control Release; 2017 Jan; 245():177. PubMed ID: 28065323
    [No Abstract]   [Full Text] [Related]  

  • 10. Liposomal Nanotechnology for Cancer Theranostics.
    Yue X; Dai Z
    Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
    Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
    Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic niosomes for direct intratumoral injection: marked enhancement in tumor retention and anticancer efficacy.
    Nowroozi F; Dadashzadeh S; Soleimanjahi H; Haeri A; Shahhosseini S; Javidi J; Karimi H
    Nanomedicine (Lond); 2018 Sep; 13(17):2201-2219. PubMed ID: 29993311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGD-TPGS decorated theranostic liposomes for brain targeted delivery.
    Sonali ; Singh RP; Sharma G; Kumari L; Koch B; Singh S; Bharti S; Rajinikanth PS; Pandey BL; Muthu MS
    Colloids Surf B Biointerfaces; 2016 Nov; 147():129-141. PubMed ID: 27497076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma.
    Wang Y; Sui G; Teng D; Wang Q; Qu J; Zhu L; Ran H; Wang Z; Jin C; Wang H
    Biomater Sci; 2018 Dec; 7(1):196-210. PubMed ID: 30422139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 16. Silver Prussian blue analogue nanomedicine for future cancer therapy.
    Haque S; Patra CR
    Future Oncol; 2021 Jan; 17(2):119-122. PubMed ID: 33244991
    [No Abstract]   [Full Text] [Related]  

  • 17. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of tagitinin C in liposomes coated by
    Tran TTT; Tran VH; Lam TT
    J Microencapsul; 2019 Jan; 36(1):53-61. PubMed ID: 30784339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.
    Muthu MS; Feng SS
    Expert Opin Drug Deliv; 2013 Feb; 10(2):151-5. PubMed ID: 23061654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile Supramolecular Approach to Nucleic-Acid-Driven Activatable Nanotheranostics That Overcome Drawbacks of Photodynamic Therapy.
    Li X; Yu S; Lee D; Kim G; Lee B; Cho Y; Zheng BY; Ke MR; Huang JD; Nam KT; Chen X; Yoon J
    ACS Nano; 2018 Jan; 12(1):681-688. PubMed ID: 29232105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.